[Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome]
- PMID: 2414802
[Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome]
Abstract
A prospective study was carried out on a group of 28 patients affected by nephrotic syndrome in order to compare the antithrombin activity, measured by the technique of Howie, the antithrombin III, measured with chromogenic substrate and by radial immunodiffusion, the alpha 2-macroglobulin and the alpha 1-antitrypsin. An increased level of alpha 2-macroglobulin and of the antithrombin activity, measured by the technique of Howie and a reduction of the level of antithrombin III and of alpha 1-antitrypsin was observed. It is suggested that the increased antithrombin activity is related to the increase of alpha 1-antitrypsin was observed. It is suggested that the increased antithrombin activity is related to the increase of alpha 2-macroglobulin concentration in spite of the simultaneous decrease of antithrombin III.
Similar articles
-
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.Thromb Haemost. 1981 Oct;46(3):623-5. Thromb Haemost. 1981. PMID: 6171906
-
Concentration of three thrombin inhibitors in the nephrotic syndrome in adults.Nephron. 1986;42(3):200-3. doi: 10.1159/000183667. Nephron. 1986. PMID: 2418377
-
[A study of antithrombin systems during heparin therapy].Nouv Presse Med. 1982 Oct 16;11(41):3043-6. Nouv Presse Med. 1982. PMID: 6183640 French.
-
Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.Prog Hemost Thromb. 1976;3:145-89. Prog Hemost Thromb. 1976. PMID: 59937 Review. No abstract available.
-
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.Semin Thromb Hemost. 1982 Oct;8(4):288-301. doi: 10.1055/s-2007-1005059. Semin Thromb Hemost. 1982. PMID: 6817417 Review. No abstract available.